167 related articles for article (PubMed ID: 35282415)
1. Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool.
Herrero-Aguayo V; Sáez-Martínez P; Jiménez-Vacas JM; Moreno-Montilla MT; Montero-Hidalgo AJ; Pérez-Gómez JM; López-Canovas JL; Porcel-Pastrana F; Carrasco-Valiente J; Anglada FJ; Gómez-Gómez E; Yubero-Serrano EM; Ibañez-Costa A; Herrera-Martínez AD; Sarmento-Cabral A; Gahete MD; Luque RM
Mol Ther Nucleic Acids; 2022 Mar; 27():1164-1178. PubMed ID: 35282415
[TBL] [Abstract][Full Text] [Related]
2. In1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate Cancer.
Jiménez-Vacas JM; Montero-Hidalgo AJ; Gómez-Gómez E; Fuentes-Fayos AC; Ruiz-Pino F; Guler I; Camargo A; Anglada FJ; Carrasco-Valiente J; Tena-Sempere M; Sarmento-Cabral A; Castaño JP; Gahete MD; Luque RM
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4956-e4968. PubMed ID: 34255835
[TBL] [Abstract][Full Text] [Related]
3. Influence of Obesity in the miRNome: miR-4454, a Key Regulator of Insulin Response Via Splicing Modulation in Prostate.
Herrero-Aguayo V; Jiménez-Vacas JM; Sáez-Martínez P; Gómez-Gómez E; López-Cánovas JL; Garrido-Sánchez L; Herrera-Martínez AD; García-Bermejo L; Macías-González M; López-Miranda J; Castaño JP; Gahete MD; Luque RM
J Clin Endocrinol Metab; 2021 Jan; 106(2):e469-e484. PubMed ID: 32841353
[TBL] [Abstract][Full Text] [Related]
4. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
[TBL] [Abstract][Full Text] [Related]
5. Seminal plasma microRNAs improve diagnosis/prognosis of prostate cancer in men with moderately altered prostate-specific antigen.
Barceló M; Castells M; Pérez-Riba M; Bassas L; Vigués F; Larriba S
Am J Transl Res; 2020; 12(5):2041-2051. PubMed ID: 32509198
[TBL] [Abstract][Full Text] [Related]
6. Combinations of elevated tissue miRNA-17-92 cluster expression and serum prostate-specific antigen as potential diagnostic biomarkers for prostate cancer.
Feng S; Qian X; Li H; Zhang X
Oncol Lett; 2017 Dec; 14(6):6943-6949. PubMed ID: 29163712
[TBL] [Abstract][Full Text] [Related]
7. Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer.
Byun YJ; Piao XM; Jeong P; Kang HW; Seo SP; Moon SK; Lee JY; Choi YH; Lee HY; Kim WT; Lee SC; Cha EJ; Yun SJ; Kim WJ
Investig Clin Urol; 2021 May; 62(3):340-348. PubMed ID: 33834642
[TBL] [Abstract][Full Text] [Related]
8. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
9. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
10. Detection of miRNAs in urine of prostate cancer patients.
Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
[TBL] [Abstract][Full Text] [Related]
11. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
12. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Peripheral Blood miR-374b-5p in Patients with Prostate Cancer.
Pang C; Song X; Fu C; Zhang Y; Zhang Y; Liu M
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013356
[TBL] [Abstract][Full Text] [Related]
15. Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.
Al-Kafaji G; Said HM; Alam MA; Al Naieb ZT
Oncol Lett; 2018 Jul; 16(1):1357-1365. PubMed ID: 30061955
[TBL] [Abstract][Full Text] [Related]
16. Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer.
Gómez-Gómez E; Jiménez-Vacas JM; Carrasco-Valiente J; Herrero-Aguayo V; Blanca-Pedregosa AM; León-González AJ; Valero-Rosa J; Fernández-Rueda JL; González-Serrano T; López-Miranda J; Gahete MD; Castaño JP; Requena-Tapia MJ; Luque RM
J Cell Mol Med; 2018 Nov; 22(11):5688-5697. PubMed ID: 30256519
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate Cancer.
Borkowetz A; Lohse-Fischer A; Scholze J; Lotzkat U; Thomas C; Wirth MP; Fuessel S; Erdmann K
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32784833
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of microRNAs in prostate cancer patients with prostate specific antigen (PSA) levels between 2, and 10 ng/mL.
Akbayır S; Muşlu N; Erden S; Bozlu M
Turk J Urol; 2016 Dec; 42(4):247-255. PubMed ID: 27909617
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Validation of Novel microRNA Panel for Non-Invasive Prediction of Prostate Cancer.
Kumari S; Manoj A; Rungta S; Kumar M; Prasad G; Kumar D; Mahdi AA; Ahmad MK
Cureus; 2024 Apr; 16(4):e58207. PubMed ID: 38741808
[TBL] [Abstract][Full Text] [Related]
20. miRNA in Prostate Cancer: New Prospects for Old Challenges.
Mekhail SM; Yousef PG; Jackinsky SW; Pasic M; Yousef GM
EJIFCC; 2014 Apr; 25(1):79-98. PubMed ID: 27683458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
